HC Wainwright Increases Earnings Estimates for Spectral AI

Spectral AI, Inc. (NASDAQ:MDAI) – Equities researchers at HC Wainwright increased their FY2027 earnings estimates for Spectral AI in a research report issued to clients and investors on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings per share of $0.63 for the year, up from their previous estimate of $0.53. HC Wainwright currently has a “Buy” rating and a $3.50 target price on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.64) per share. HC Wainwright also issued estimates for Spectral AI’s FY2028 earnings at $0.46 EPS.

Spectral AI (NASDAQ:MDAI) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The company had revenue of $7.48 million for the quarter, compared to analysts’ expectations of $6.00 million.

Several other equities research analysts have also commented on the stock. Northland Capmk upgraded shares of Spectral AI to a “strong-buy” rating in a research note on Monday, August 12th. Northland Securities assumed coverage on shares of Spectral AI in a research note on Monday, August 12th. They issued an “outperform” rating and a $6.00 price target on the stock.

Spectral AI Stock Down 11.3 %

MDAI opened at $1.34 on Friday. The firm has a market cap of $24.80 million, a price-to-earnings ratio of -1.01 and a beta of 0.48. Spectral AI has a fifty-two week low of $0.82 and a fifty-two week high of $3.72. The company’s 50-day moving average price is $1.26 and its 200 day moving average price is $1.54.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Murchinson Ltd. bought a new position in shares of Spectral AI in the first quarter valued at approximately $85,000. Forum Financial Management LP bought a new position in shares of Spectral AI in the second quarter valued at approximately $51,000. Finally, Virtu Financial LLC bought a new position in shares of Spectral AI in the first quarter valued at approximately $38,000. 67.08% of the stock is currently owned by institutional investors.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.